Item 5. Market for Registrant’s Common Equity
ITEM
5. Market
for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of
Equity Securities.
Market
Information
Our
common stock is listed and traded on the NYSE American under the symbol AIM.
Holders
of Common Stock
As
of March 25, 2023, there were approximately 150 holders of record of our Common Stock. This number was determined from records maintained
by our transfer agent and does not include beneficial owners of our securities whose securities are held in the names of various dealers
and/or clearing agencies.
Securities
Authorized for Issuance Under Equity Compensation Plans
Information
about securities authorized for issuance under our equity compensation plans is incorporated herein by reference to Item 12 of Part III
of this Annual Report.
Dividends
We
have not paid any cash dividends on our Common Stock in recent years. It is management’s intention not to declare or pay dividends
on our Common Stock, but to retain earnings, if any, for the operation and expansion of our business.
Recent
Sales of Unregistered Securities
During
the year ended December 31, 2022, we issued and sold the following unregistered securities under the 2018 Equity Incentive Plan, effective
September 12, 2018, which will continue in effect for a period of 10 years from its effective date:
On
July 7, 2020, the board of directors approved a plan pursuant to which all directors, officers, and employees could purchase from us
up to an aggregate of $500,000 worth of shares at the market price. Pursuant to NYSE American rules, this plan was effective for a sixty-day
period commencing upon the date that the NYSE American approved the our Supplemental Listing Application. We issued 10,730 shares of
our common stock at a price of $2.33 for a total of $25,000 under this plan. When this plan expired, the board of directors approved
subsequent similar $500,000 plans for all directors, officers and employees to buy shares from us at the market price. Subsequent plans
were approved by the board of directors upon the expiration of prior plans. The last plan approved by the board of directors for the
fiscal year ending December 31, 2022, was on November 16, 2022.
During
the fiscal year ended December 31, 2020, we issued a total of 27,501 shares of our common stock at prices ranging from $1.72 to $2.03
for a total of $50,000.
During
the fiscal year ended December 31, 2021, we issued a total of 132,238 shares of our common stock at prices ranging from $1.16 to $2.35
for a total of $205,000.
During
the fiscal year ended December 31, 2022, we issued a total of 86,817 shares of our common stock at prices ranging from $0.76 to $1.02
for a total of $80,000.
35
The
offers, sales and issuances of securities described above was deemed to be exempt from registration under the Securities Act in reliance
on either Section 4(a)(2) in that the issuance of securities to the accredited investors did not involve a public offering, or Rule 701
in that the transactions were under compensatory benefit plans and contracts relating to compensation as provided under Rule 701.
ITEM
6. [Reserved]